US$ 21.06
novartis glp 1 drug Comparing Ozempic, Wegovy and Other GLP-1 Drugs Decoding GLP-1 Weight Loss Medications
Description
Model 1: crude model

95% CI, 1.74-6.22)

Important Safety Information for Ozempic (semaglutide) injection Warning: Risk of Thyroid C-Cell Tumors In studies with mice and rats, semaglutide (the active ingredient in Ozempic and Wegovy) caused thyroid tumors, including thyroid cancer

BMJ , 2026

Discontinuation of GLP1RAs and tirzepatide typically results in weight regain, deterioration of glycaemic control and the loss of previous improvements in cardiometabolic markers
